You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
長江健康(002435.SZ):設海南醫藥 以藥品進出口、批發、網絡銷售及技術進出口為主營方向
格隆匯 02-06 21:18

格隆匯2月6日丨長江健康(002435.SZ)公佈,公司全資子公司長江潤髮張家港保税區醫藥投資有限公司(“長江醫藥投資”)出資設立全資子公司長江潤髮(海南)醫藥科技有限公司(“海南醫藥”),註冊資本500萬元人民幣。

近日,公司收到海南省市場監督管理局頒發的海南醫藥《營業執照》,經營範圍:許可項目:藥品進出口;藥品批發;技術進出口;藥品零售;藥品互聯網信息服務(依法須經批准的項目,經相關部門批准後方可開展經營活動)一般項目:技術服務、技術開發、技術諮詢、技術交流、技術轉讓、技術推廣;企業管理(除許可業務外,可自主依法經營法律法規非禁止或限制的項目)

海南醫藥目前尚未開展實際業務,預計對公司2020年業績影響較小。

投資設立海南醫藥符合公司戰略發展規劃,海南醫藥將以藥品進出口、批發、網絡銷售及技術進出口為主營方向,充分利用海南自貿區對醫藥註冊特殊審批等扶持政策,積極引進各類專業技術人才,加大與國內外先進藥品生產研發企業合作,豐富產品管線,提升產品結構,逐漸擴大企業規模,致力發展成為海南自貿區醫藥進出口領軍企業。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account